Начало › Рак на пикочния мехур › Охайо › Columbus
Клинични проучвания за Рак на пикочния мехур в Columbus, OH
19 проучвания за Рак на пикочния мехур търсят участници в обекти в и около Columbus (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Набиране на участнициФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- и още 8
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Набиране на участнициФаза 2
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- Doctors Hospital, Columbus
- и още 1
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Набиране на участнициФаза 2
- Ohio State University Comprehensive Cancer Center, Columbus
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Набиране на участнициФаза 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Набиране на участнициФаза 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- и още 11
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Набиране на участнициФаза 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Набиране на участнициФаза 1
- Ohio State University, Columbus
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Набиране на участнициФаза 2
- Ohio State University, Columbus
- Central Ohio Urology Group (US Urology Partners), Gahanna · на 7 мили
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Набиране на участнициФаза 1
- The Ohio State University (OSU), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Набиране на участнициФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Набиране на участнициФаза 1/2
- Central Ohio Urology Group, Gahanna · на 7 мили
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Набиране на участнициНаблюдателно проучване
- The Ohio State University, Columbus
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Набиране на участнициФаза 2/3
- The James Outpatient Care West Campus, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набиране на участнициФаза 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Набиране на участнициФаза 2
- Ohio State University Hospital, Columbus
- Ohio State University, Columbus
- OSU Wexner Medical Center & James Cancer Hospital, Columbus
- и още 2
Blue Light Cystoscopy With Cysview® Registry
Набиране на участнициНаблюдателно проучване
- Ohio State University Wexner Medical Center, Columbus
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Columbus
Проучвания за Рак на пикочния мехур в други градове
- New York City, NY35 проучвания
- Nashville, TN31 проучвания
- Houston, TX31 проучвания
- Dallas, TX27 проучвания
- Boston, MA26 проучвания
- Washington, DC26 проучвания
- Los Angeles, CA24 проучвания
- Baltimore, MD24 проучвания
- St. Louis, MO22 проучвания
- Philadelphia, PA21 проучвания
- Seattle, WA21 проучвания
- Edison, NJ21 проучвания
Други проучвания в Columbus
- Рак на белия дроб с недребноклетъчен тип56 проучвания
- Рак на гърдата39 проучвания
- Рак на яйчниците39 проучвания
- Рак (всички видове)38 проучвания
- Рак на белия дроб37 проучвания
- Остра миелоидна левкемия35 проучвания
- Хронична лимфоцитна левкемия28 проучвания
- Метастатичен рак27 проучвания
- Ендометриален рак25 проучвания
- Колоректален рак24 проучвания
- Рак на простатата24 проучвания
- Множествен миелом24 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.